div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documentcoreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancyhtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: coreacuk · 2017 3 23 · nant tumor in Korea comprising 307% of all malignancy during period of study Among malignant lymphomas non-Hodgkins lymphoma accounted for 82% and loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumentsinreader033viewer202206091060a46e31e4d2b25c6d74504chtml5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documentcoreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancyhtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: coreacuk · 2017 3 23 · nant tumor in Korea comprising 307% of all malignancy during period of study Among malignant lymphomas non-Hodgkins lymphoma accounted for 82% and loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumentsinreader033viewer202206091060a46e31e4d2b25c6d74504chtml5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=documentcoreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancyhtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: coreacuk · 2017 3 23 · nant tumor in Korea comprising 307% of all malignancy during period of study Among malignant lymphomas non-Hodgkins lymphoma accounted for 82% and loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumentsinreader033viewer202206091060a46e31e4d2b25c6d74504chtml5thumbnails3jpg...